Overview
Congna Tian practices practicing medicine in Shijiazhuang, China.
Tian is highly rated in 1 condition, according to our data. Their clinical expertise encompasses Lymphofollicular Hyperplasia, Lung Adenocarcinoma, and Secondary Peritonitis.
They are actively involved in clinical research, co-authoring 19 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Congna J. Tian
Is Congna J. Tian a top-rated expert for Lymphofollicular Hyperplasia?
MediFind is an objective health platform that identifies experts based on real-world data. Congna J. Tian is classified as an Advanced expert for Lymphofollicular Hyperplasia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Congna J. Tian participate in research or clinical trials?
Yes. Congna J. Tian has published 19 articles and abstracts on conditions like Lymphofollicular Hyperplasia. You can view a list of Congna J. Tian's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Lymphofollicular Hyperplasia
- Experienced
- Lung AdenocarcinomaTian isExperienced. Learn about Lung Adenocarcinoma.
- Secondary PeritonitisTian isExperienced. Learn about Secondary Peritonitis.